Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case report

Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)-induced interstitial lung disease (ILD) may be a life-threatening condition that may develop during treatment of lung cancer patients harboring EGFR mutations. We herein present the case of a 41-year-old female patient diagnosed w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Clin Oncol
Autores principales: Tani, Tetsuo, Naoki, Katsuhiko, Asakura, Takanori, Hirano, Toshiyuki, Suzuki, Shoji, Masuzawa, Keita, Hasegawa, Hanako, Kuroda, Aoi, Yasuda, Hiroyuki, Ishii, Makoto, Soejima, Kenzo, Betsuyaku, Tomoko
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038222/
https://ncbi.nlm.nih.gov/pubmed/27699048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.981
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares